U.S. Logistics Stock News

AbCellera Biologics Inc. recently appointed Lynn Seely, M.D., president and CEO of Lyell Immunopharma and former Myovant Sciences chief executive, to its Board of Directors as an independent director, adding deep experience in oncology and commercializing complex therapies. Her background leading drug programs from first-in-human trials through approvals and major acquisitions may influence how AbCellera shapes its pipeline priorities and commercialization plans. We’ll now examine how adding...

Excelerate Energy (EE) has been added to several Russell growth indexes, including the Russell 2000 and Russell 3000 series. This development may influence how index funds and institutional investors approach the stock. See our latest analysis for Excelerate Energy. Excelerate Energy's recent inclusion in multiple Russell growth indexes arrives after a strong period for the stock, with a 30 day share price return of 20.14% and a year to date share price return of 36.63%, while the 1 year...

In late June 2026, Beam Therapeutics Inc. (NasdaqGS: BEAM) was added to several Russell Value benchmarks, including the Russell 3000E, 3000, 2500, 2000, and Small Cap Comp indices. This broad inclusion across the Russell Value family can influence trading activity as index-tracking funds and value-focused investors adjust their portfolios to reflect the new constituent. Now we'll examine how Beam’s broad inclusion in Russell Value indices may shape its investment narrative around gene...

Keurig Dr Pepper has recently advanced its planned split into two independent public companies, announced leadership transitions in its coffee and finance teams, filed a US$1.66 billion shelf registration for ESOP-related common shares, and been reclassified across multiple Russell indexes. These moves collectively reshape how the market may view Keurig Dr Pepper’s future coffee and beverage businesses, governance structure, and investor base as the separation approaches. We’ll now examine...

In recent days, Guardant Health announced that its Shield blood test for colorectal cancer screening is now covered for eligible UnitedHealth Group members aged 45 and over, making UnitedHealth the first major commercial insurer to reimburse this non-invasive test across its roughly 40 million-strong US membership base. This coverage expansion could strengthen UnitedHealth’s role in preventive care by widening access to innovative cancer screening technology at a time of rising colorectal...

In late June 2026, Permian Resources Corporation (NYSE: PR) was added to multiple Russell Growth benchmarks, including the Russell 1000, 2500, Midcap, Small Cap Comp, 3000, and 3000E Growth indices. This broad index inclusion follows a period of strong operational execution and industry support that has drawn increased attention from institutional investors. Next, we’ll examine how this extensive Russell Growth index inclusion could influence Permian Resources’ existing investment narrative...

On 27 June 2026, The Andersons, Inc. was added to multiple Russell growth benchmarks, including the Russell 2000 Growth, 2500 Growth, 3000 Growth, 3000E Growth, Small Cap Comp Growth, and 2000 Growth-Defensive indices. This cluster of index inclusions can meaningfully broaden Andersons’ investor base as passive and benchmark-aware funds adjust their holdings to reflect the changes. We’ll now examine how Andersons’ broad Russell growth index additions might reinforce or challenge the...

Recently, Universal Display Corporation gained attention as the broader semiconductor sector recovered on upbeat Wall Street commentary and new multi-year supply agreements. At the same time, Executive Vice President and Chief Technical Officer Dr. Julie Brown received the prestigious IEEE Frederik Philips Award, highlighting Universal Display’s leadership in phosphorescent OLED innovation and its role in the shift from LCDs to more power-efficient OLED displays. We’ll now explore how...

The Federal Reserve’s renewed push to tighten oversight, modernize its rulebook and bring blockchain activity firmly under the regulatory umbrella is putting fintech stocks in the spotlight. For investors, this is a moment to reassess which companies could benefit from clearer rules, stronger security expectations and closer links to digital payments and crypto infrastructure, and which might face heavier compliance burdens. This article looks at 3 stocks from a fintech focused screener that...

Meta Platforms (NasdaqGS:META) has launched Pocket, a new AI-driven mobile gaming app, expanding its consumer AI entertainment offerings. The company has also introduced a branded AI Glasses collection for the mass market in partnership with EssilorLuxottica, with a global rollout. At the same time, Meta faces a US$1.4 trillion lawsuit from four US states alleging youth addiction risks linked to its platforms. Meta Platforms, best known for Facebook, Instagram and WhatsApp, is pushing...

Why Diodes Stock Is Back on Investors’ Radar Diodes (DIOD) has just been added to several Russell growth benchmarks, including the Russell 2000 Growth and Russell 3000 Growth indexes, putting the stock in front of more benchmark-driven investors. See our latest analysis for Diodes. Those index additions come after a strong run, with Diodes’ share price at $97.64 and a 90 day share price return of 33.24% alongside a 1 year total shareholder return of 78.76%. This suggests momentum has been...

CNX Resources Corporation was recently removed from the Russell 2000 Dynamic Index, a change that could influence institutional ownership patterns and index-linked fund holdings. This index removal may alter how investors assess CNX’s access to capital and visibility just as it prepares to report Q2 2026 results. We’ll now examine how CNX’s exit from the Russell 2000 Dynamic Index could reshape the company’s investment narrative and risk profile. The future of work is here. Discover the...

Amylyx Pharmaceuticals (AMLX) has just been removed from several Russell equity indexes, a technical event that can prompt index tracking funds to adjust holdings and influence short term trading patterns in the stock. See our latest analysis for Amylyx Pharmaceuticals. Despite the index removals and a 1-day share price return of 1.64% and 7-day share price return of 3.9% at the latest close of $17.97, Amylyx Pharmaceuticals still has a 30-day share price return of 34.91% and a year to date...

Viking Therapeutics (VKTX) is back in focus after launching a Phase 1 trial for VK3019, a dual amylin and calcitonin receptor agonist for weight loss, while it advances its late stage obesity candidate VK2735. See our latest analysis for Viking Therapeutics. Viking Therapeutics' recent VK3019 trial news lands after a strong run in the stock, with a 30 day share price return of 36.06% and a 1 year total shareholder return of 40.71%. The 3 year total shareholder return of 142.24% and very large...

In late June 2026, BKV Corporation announced that its Eagle Ford carbon capture and sequestration facility in South Texas had started operations, joining the Barnett Zero and Cotton Cove projects to form a three-site commercial CCS network across Texas. This expansion, underpinned by BKV’s joint venture with Copenhagen Infrastructure Partners and the retention of environmental credits, underscores the company’s push to integrate carbon management with its natural gas and midstream...

In late June 2026, MYR Group Inc. was removed from the Russell 2000 Dynamic Index, a benchmark followed by various index-linked investors. This index removal can alter ownership patterns and trading activity, as funds that replicate the benchmark adjust their holdings in MYR Group. We'll now explore how MYR Group's removal from the Russell 2000 Dynamic Index may influence its investment narrative and future positioning. Invest in the nuclear renaissance through our list of 89 elite nuclear...

Borr Drilling (BORR) has drawn fresh attention after completing a US$360 million acquisition of five premium jack up rigs from Noble Corporation and agreeing to acquire five additional rigs through a new joint venture. See our latest analysis for Borr Drilling. Borr Drilling’s share price, now at US$4.47, has seen mixed momentum, with a 7 day share price return of 6.18% but a 90 day share price return down 25.13%. At the same time, the 1 year total shareholder return of 113.88% and 5 year...

Kennametal Inc. was recently added to multiple Russell growth indices, including the Russell 2000 Growth and Russell 3000 Growth, while also naming Amanda Cole as its new Chief Human Resources Officer, effective July 21, 2026, succeeding long-time HR leader Judith Bacchus upon her planned retirement around October 1, 2026. The simultaneous inclusion in several Russell benchmarks and the appointment of a CHRO overseeing global HR, communications and EHSQ functions together highlight how...

Earlier this month, Vertex Pharmaceuticals reported U.S. FDA approval to expand use of its CRISPR-based gene therapy CASGEVY to children as young as two with sickle cell disease or transfusion-dependent beta thalassemia, making it the first genetic treatment available to this pediatric group in the U.S. By opening access to this one-time therapy to thousands of additional young patients while also advancing reimbursement for its new cystic fibrosis regimen ALYFTREK in Canada, Vertex is...

In recent months, ANI Pharmaceuticals reported strong operational progress, including 33.6% annual revenue growth over the last two years and significantly higher free cash flow margins, reflecting improved efficiency and financial flexibility. An important takeaway is that rising returns on capital suggest the company is beginning to unlock more value from past investments in its product portfolio and operations. We’ll now examine how ANI Pharmaceuticals’ stronger free cash flow...

Index change and earnings expectations put Archer-Daniels-Midland in focus Recent commentary around Archer-Daniels-Midland (ADM) has centered on a recovery in its Nutrition and Ag Services segments, with management raising full-year adjusted EPS guidance. This has supported a more constructive tone from analysts. See our latest analysis for Archer-Daniels-Midland. Beyond the index change and upgraded guidance, Archer-Daniels-Midland has attracted attention with a 1-day share price return of...

The latest move in Eli Lilly (LLY) stock comes as the Medicare GLP-1 Bridge program opens wider access to its weight management drugs, alongside strong reported earnings and supportive regulatory and partnership news. See our latest analysis for Eli Lilly. Eli Lilly’s share price has been choppy in the very near term, with a 1-day share price return that declined 1.14% and a 7-day share price return that fell 2.43%. However, the 90-day share price return of 28.89% and 1-year total shareholder...

Essent Group (ESNT) has returned to investors’ radar after Chairman, CEO and President Mark Casale disclosed an open market sale of 3,763 common shares, executed on June 30 at about $65 per share. See our latest analysis for Essent Group. Mark Casale’s recent share sale comes after a strong run in Essent Group’s stock, with a 30 day share price return of 12.34% and a 90 day gain of 7.64%, while the latest close sits at US$64.53. Over a longer horizon, Essent Group’s total shareholder return...

On 27 June 2026, Vistance Networks, Inc. (NasdaqGS: VISN) was removed from a broad suite of Russell indices, including the Russell 2500 Growth, 2000 Growth, 3000, 3000E, and multiple Microcap and style benchmarks. This extensive index removal reshapes how many passive and benchmark-aware investors gain exposure to Vistance Networks, potentially altering its shareholder base and trading profile. We’ll now examine how Vistance Networks’ broad removal from Russell indices could influence its...